Takeda Pharmaceuticals Clinches $62 Billion Acquisition Of ShireTakeda clinched the $62 billion acquisition of Ireland-based drugmaker Shire after a six-week back-and-forth. The post Takeda Pharmaceuticals Clinches $62 Billion Acquisition Of Shire appeared first on Investor's Business Daily.

[Collection]

Takeda Pharmaceuticals clinched the $62 billion acquisition of Shire (SHPG) after a six-week back-and-forth that also briefly included potential interest from Allergan, it was learned Tuesday.

X

The total deal values Shire at 49.01 pounds, or about $66.20, per share, Takeda said in a press release. All together, Takeda will pay 46 billion pounds, roughly $62.1 billion.

Under the terms of the deal, Shire shareholders will receive $30.33 in cash and either 0.839 new Takeda shares or 1.678 Takeda American Depositary Shares for each Shire share.

The companies expect the deal to close in the first half of 2019.

More to follow.

RELATED:

How Do You Spot A Major Market Top? Easy: Look For Heavy Distribution

How To Tame A Volatile Swing Trade With A Half Position

Looking For The Best Stocks To Buy And Watch? Start Here

The post Takeda Pharmaceuticals Clinches $62 Billion Acquisition Of Shire appeared first on Investor's Business Daily.

http://feedproxy.google.com/~r/BusinessRss/~3/LSkVMmNuF-I/